Clinical trial
Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
NCT03782636 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD)
- Lead sponsor
- University of Oxford
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- January 28, 2019
- Completion date
- September 30, 2026
- Enrollment
- 41 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
type1 diabetes